安进公司因olpasiran相关担忧下跌10%（AMGN:纳斯达克）
· seekingalpha.com
诺华公司的pelacarsen三期临床试验失败引发对安进olpasiran的担忧，安进股价下跌10%。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...